On May 10, 2022, FDA published draft guidance entitled, “Benefit-Risk Considerations for Product Quality Assessments”, which describes...
This browser is not actively supported anymore. For the best passle experience, we strongly recommend you upgrade your browser.
Reed Smith LLP
Updates by Reed Smith on U.S. legislative & regulatory developments affecting the health care industry